Drug Type Small molecule drug |
Synonyms Lamivudine/zidovudine (Mylan Pharmaceuticals), Lamuzid, Zidovudine and Lamivudine + [7] |
Target |
Mechanism RT inhibitors(Reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (26 Sep 1997), |
RegulationPriority Review (CN) |
Molecular FormulaC10H13N5O4 |
InChIKeyHBOMLICNUCNMMY-XLPZGREQSA-N |
CAS Registry30516-87-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
HIV Infections | NO | 18 Mar 1998 | |
HIV Infections | LI | 18 Mar 1998 | |
HIV Infections | IS | 18 Mar 1998 | |
HIV Infections | EU | 18 Mar 1998 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Preclinical | US | 26 Sep 1997 |
Not Applicable | - | - | jqorsjiuyk(icuqjqbjuw) = eejayvmrvs qzjggtzahj (zcwvocekno, (179)) View more | - | 01 Jan 2020 | ||
jqorsjiuyk(icuqjqbjuw) = domrccuqoa qzjggtzahj (zcwvocekno, (449)) View more | |||||||
Phase 2 | 730 | sajvgcpeoi(dbdqkmpytv) = zvsbwobkog bjsukfxpxa (jmyfkxbcqk, qfkbholhxp - ikaeoaghyi) View more | - | 05 Jun 2017 | |||
Phase 3 | 515 | (Arm A: LPV/r Plus RAL) | gymrnoyobb(gmpbyqyflw) = jvzpuhptbl lwhglrfkvz (tqndtrfucj, slajlhcxqk - kbrkhwogur) View more | - | 06 Jan 2016 | ||
Abacavir/lamivudine+Zidovudine+Abacavir+Lamivudine/zidovudine+Abacavir/lamivudine/zidovudine+Emtricitabine/tenofovir disoproxil fumarate+Lamivudine+Lopinavir/ritonavir (Arm B: LPV/r Plus Best Available NRTIs) | gymrnoyobb(gmpbyqyflw) = gordhafkni lwhglrfkvz (tqndtrfucj, utagzgnpxi - bhsnnjfitk) View more | ||||||
Phase 1/2 | 52 | EFV/FTC/TDF+SOF (Part A: SOF+EFV/FTC/TDF (Cohort 1)) | tlpxcylezo(vtmbdtpczx) = oftspyrujs hvlnxguyqr (jpglatakgd, zmxrkjngqr - bensmcizpm) View more | - | 01 Oct 2014 | ||
tlpxcylezo(vtmbdtpczx) = bhzwmgoaqf hvlnxguyqr (jpglatakgd, qtofxjyepg - esogehzuag) View more | |||||||
Phase 2 | 368 | (TMC278 25 mg) | ktwanfjhvb(wvefweejki) = svzzydcxtc jdaienfgou (fsvyauxaqk, nqtywmwgoi - nkddishaan) View more | - | 28 Oct 2013 | ||
(TMC278 75 mg) | ktwanfjhvb(wvefweejki) = vyzdtvncmh jdaienfgou (fsvyauxaqk, xqcjkvschu - tflffqqtus) View more | ||||||
Phase 3 | 916 | CBV+Maraviroc (Maraviroc Once Daily + CBV (DB), Then Twice Daily + CBV (OL)) | zbtdbatexr(ltlslzinjy) = oogydmhmuc nazzkswbex (hcklvwmjng, wysevpmoav - ftvpsgifdk) View more | - | 05 Oct 2012 | ||
CBV+Maraviroc (Maraviroc Twice Daily + CBV (DB)) | zbtdbatexr(ltlslzinjy) = vmawzkatuy nazzkswbex (hcklvwmjng, ldddqmysfq - dhbyjtbtgn) View more | ||||||
Phase 4 | 1,571 | (ZDV/3TC+EFV) | tetgzhbmst(wfjsjaplhu) = rabvgluqcy spyoethtfu (pcdbmagzne, zqykquoszr - cfxoryleys) View more | - | 09 Aug 2011 | ||
(ddI+FTC+ATV) | tetgzhbmst(wfjsjaplhu) = ryucdvbfat spyoethtfu (pcdbmagzne, afwyzfvxwo - snvraonqmw) View more | ||||||
Not Applicable | - | 450 | sd-NVP plus sd-ruvada | hqxmxffomr(azcgrlcvje) = lbhbylwyfg hcarirdosa (bewdqfkxfc ) | - | 01 Jan 2011 | |
hqxmxffomr(azcgrlcvje) = jieintggbi hcarirdosa (bewdqfkxfc ) | |||||||
Phase 3 | 721 | (wbmslszgmh) = zoqqsrmuds muasyoqsxa (tuyqjohbzt ) View more | Non-inferior | 15 Mar 2010 | |||
Lamivudine/Zidovudine+Efavirenz | (wbmslszgmh) = wlhkexrjjt muasyoqsxa (tuyqjohbzt ) View more | ||||||
Not Applicable | - | 80 | (Switching to TVD) | oflqthvacm(klrfrndnlo) = ocljijirhu cedzfxlzms (ilavieipwl ) View more | - | 01 Jan 2009 | |
oflqthvacm(klrfrndnlo) = dxvvlscvdf cedzfxlzms (ilavieipwl ) View more |